1979
DOI: 10.1016/0005-2795(79)90151-x
|View full text |Cite
|
Sign up to set email alerts
|

Resolution of the major hemorrhagic component of Trimeresurus flavoviridis venom into two parts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
13
0

Year Published

1980
1980
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 58 publications
(14 citation statements)
references
References 21 publications
1
13
0
Order By: Relevance
“…P-IIIc has been reported for HV1 from P. flavoviridis venom, VAP1 from C. atrox venom, VLAIPs from V. lebetina venom, and TSV-DM from P. stejnegeri venom, and most of these proteins were shown to induce apoptosis in vascular endothelial cells (Masuda et al, 2001(Masuda et al, , 2000(Masuda et al, , 1997Samel et al, 2012;Trummal et al, 2005;Wan et al, 2006). Many P-IIIc SVMPs, such as VAP1 (MHD: 8 mg) from C. atrox (Kikushima et al, 2008) and VaH3 (MHD: 10 mg) from Vipera ammodytes (Sajevic et al, 2013), exhibit weaker hemorrhagic activities than those of with P-IIIa/b SVMPs, such as atrolysin A (HTa) (MHD: 0.04 mg) from C. atrox (Bjarnason and Tu, 1978) and HR1B (MHD: 0.01 mg) from P. flavoviridis (Omori-Satoh and Sadahiro, 1979). In the present study, hemorrhagic activity was measured in a maximum amount of 1 mg. SV-PAD-2 may also show hemorrhagic activity at doses of 10 mg or more because the MHD of VAP1 and VaH3, belonging to class P-IIIc, were 8 mg and 10 mg, respectively.…”
Section: Discussionmentioning
confidence: 98%
“…P-IIIc has been reported for HV1 from P. flavoviridis venom, VAP1 from C. atrox venom, VLAIPs from V. lebetina venom, and TSV-DM from P. stejnegeri venom, and most of these proteins were shown to induce apoptosis in vascular endothelial cells (Masuda et al, 2001(Masuda et al, , 2000(Masuda et al, , 1997Samel et al, 2012;Trummal et al, 2005;Wan et al, 2006). Many P-IIIc SVMPs, such as VAP1 (MHD: 8 mg) from C. atrox (Kikushima et al, 2008) and VaH3 (MHD: 10 mg) from Vipera ammodytes (Sajevic et al, 2013), exhibit weaker hemorrhagic activities than those of with P-IIIa/b SVMPs, such as atrolysin A (HTa) (MHD: 0.04 mg) from C. atrox (Bjarnason and Tu, 1978) and HR1B (MHD: 0.01 mg) from P. flavoviridis (Omori-Satoh and Sadahiro, 1979). In the present study, hemorrhagic activity was measured in a maximum amount of 1 mg. SV-PAD-2 may also show hemorrhagic activity at doses of 10 mg or more because the MHD of VAP1 and VaH3, belonging to class P-IIIc, were 8 mg and 10 mg, respectively.…”
Section: Discussionmentioning
confidence: 98%
“…A highly purified hemorrhagic principle (HR 1 B) was obtained as described previously (15). HR1B at 2 mg/ml was detoxified at 37 C at three different pH values.…”
Section: Methodsmentioning
confidence: 99%
“…Several SVMPs, HSF, and 5 hSSPs were prepared as previously described. 18,23,[26][27][28] The serum was fractionated by cold ethanol precipitation 7) with 0.5, 0.75, 1.25, and 2.0 volumes of ethanol, respectively, yielding E 0.5 , E 0.75 , E 1.25 , and E 2.0 . NBromosuccinimide (NBS), thermolysin, 2,4,6-trinitrobenzenesulphonic acid (TNBS), and trypsin were purchased from Sigma Chemical Co. (St. Louis, MO, USA).…”
Section: Materials and Animalsmentioning
confidence: 99%